Tagged with MEA

MEA In the February edition of DIA’s Global Forum magazine Sybil Nana Ama Ossei-Agyeman-Yeboah of the West African Health Organization, Jane H. Mashingia from the East African Community Medicines Regulatory Harmonization Programme, and the Bill & Melinda Gates Foundation’s David Mukanga examine the state of joint assessment procedures in the East…

Egypt All the latest news stories from Egypt’s healthcare and life sciences industry, including Egypt’s health insurance authority’s plans to add 100 new medical services, how the COVID-19 Omicron variant threatens to overwhelm the country’s healthcare system, and a new tie-up between Siemens Healthineers and Alameda Group.   Egypt’s health insurance…

Global Over two years since the first cases of COVID-19, the world is still coming to terms with the virus. While vaccines have been developed and rolled out in record time in high-income countries, the developing world risks falling behind. Less than ten percent of the African continent has been vaccinated,…

MEA Seasoned executive Mohamed Nasser currently oversees 16 markets for Amgen across the MEA region, including its most important – Saudi Arabia. He shares some of the key skills that pharma executives overseeing his region need to succeed.   As region head for a company that is only 40 years old,…

MEA The top 10 fastest growing pharma companies in the Middle East and Africa (region) ranked by previous period growth between MAT Q2 2020 and MAT Q2 2021. The list is dominated by regional players including Julphar, Sedico/Acdima and Eva Pharma, but multinational firms are also represented by Gilead Sciences, Takeda,…

Saudi Arabia Historic Saudi healthcare firm Tamer Group has transitioned from a distributor into one of the country’s leading fully-fledged pharmaceutical companies since the 1990s, aided in large part by strategic partnerships with leading Japanese firms. With the family-owned firm seeking further progression, Chairman and Managing Partner Aymen Tamer highlights his vision…

Saudi Arabia Jamie Phares, Managing Director, Janssen, the Pharmaceutical Companies of Johnson & Johnson in the GCC, comments on the evolving approach to healthcare provision in the region, the role of Saudi Arabia in the regional healthcare market, and what the country needs to further develop its biopharma sector. In addition, she…

MEA The top 10 pharma companies in the Middle East and Africa (region) ranked by IQVIA’s 2021 sales figure data. The list is dominated by multinational players, with Hikma the only regional representative, and these 10 corporations account for 36 percent of the total market. French giant Sanofi sits in first…

Global PharmaBoardroom’s network of thought leaders provided some of our best-read content in 2021 on topics ranging from China’s National Reimbursement Drug List to the vaccine row that erupted between AstraZeneca and the EU, the skills that pharma leaders need in the MEA region, the year’s most prominent trends, and how…

Saudi Arabia Amr Seif introduces the evolution in Astellas’ MEA strategy; the adoption of innovative access models to ensure that the companies’ therapies are available for all patients who need them; and the challenges and opportunities in the Saudi pharma market.   We are opening a new chapter in medicine. The early…

Saudi Arabia After almost two decades with MSD, Ashraf Mallak, managing director for the company in the GCC region, dives into the often-overlooked healthcare capabilities of the Gulf countries, including the fact that certain products approved by the US FDA can sometimes be available in the region in as little as one…

Turkey Johnson & Jonhson Medical’s general manager for Turkey, Maghreb, Iran, and Sub-Saharan Africa, Refik Öner, speaks about the big potential for his region “as the global economic centre of gravity moves east,” and reflects on his two-decade career in consumer goods. Moreover, Refik explains how money collection issues are constraining…